Cartesian Therapeutics Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| 795.3% | 564.3% | 10,762.0% | 60,330.8% | 50,740.7% | 112,417.6% | 30,488.2% | – | – | 608.2% | 32,030.0% | 65,115.4% | – | 403.5% | – | – | – | – | – | – | – | – | 1.9% | 1.3% | 2.6% | 3.6% | 313.6% | 338.8% | 198.5% | 1.5% | 3.1% | 0.6% | 73.9% | – | – | – | 2,831.2% | – | – | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -30,488.2% | – | – | 100.0% | 100.0% | 100.0% | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 98.1% | 98.7% | 97.4% | 96.4% | -213.6% | -238.8% | -98.5% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | -2,731.2% | 100.0% | 100.0% | – | – | |
| 574.5% | 376.6% | 8,061.3% | 42,284.6% | 35,200.0% | 80,135.3% | 65,523.5% | – | – | 1,135.8% | 73,530.0% | 93,338.5% | – | 227.7% | 221.3% | – | 300.5% | 126.3% | 117.7% | 73.6% | 85.8% | 67.9% | 52.0% | 48.8% | 79.9% | 112.9% | 313.6% | 338.8% | 198.5% | 271.4% | 166.7% | 37.9% | 2,945.7% | – | 1,334.0% | 4,989.6% | 3,053.5% | 1,551.1% | 24,952.6% | – | 4,630.0% | |
| 238.1% | 196.5% | 2,828.5% | 18,857.7% | 16,211.1% | 33,358.8% | 27,494.1% | – | – | 569.9% | 45,130.0% | 31,646.2% | – | 61.2% | 61.6% | – | 95.1% | 39.8% | 47.1% | 24.1% | 22.3% | 18.5% | 16.3% | 15.9% | 27.9% | 37.7% | 81.7% | 97.9% | 86.2% | 268.2% | 161.8% | 21.0% | 1,695.6% | – | 755.9% | 2,429.5% | 1,458.0% | 865.6% | 9,120.5% | – | 2,073.5% | |
| 812.6% | 573.0% | 10,889.8% | 61,142.3% | 51,411.1% | 113,494.1% | 93,017.6% | – | – | 1,705.6% | 118,660.0% | 124,984.6% | – | 288.9% | 282.9% | – | 395.6% | 166.1% | 164.8% | 97.7% | 108.1% | 86.4% | 66.4% | 63.4% | 105.1% | 147.0% | 95.9% | 116.3% | 101.0% | 539.5% | 328.6% | 58.9% | 4,641.3% | – | 2,089.9% | 7,419.1% | 1,929.4% | 2,416.7% | 34,073.1% | – | 5,913.3% | |
| -712.6% | -473.0% | -10,789.8% | -61,042.3% | -51,311.1% | -113,394.1% | -93,017.6% | – | – | -1,605.6% | -118,560.0% | -124,884.6% | – | -188.9% | -282.9% | – | -295.6% | -66.1% | -64.8% | 2.3% | -8.1% | 13.6% | 31.7% | 35.3% | -7.7% | -50.6% | -309.5% | -355.1% | -199.4% | -439.5% | -228.6% | 41.1% | -4,541.3% | – | -1,989.9% | -7,319.1% | -4,660.6% | -2,316.7% | -33,973.1% | – | -6,679.7% | |
| 29.7% | 11.0% | 219.0% | 1,073.1% | 992.6% | 2,111.8% | 2,058.8% | – | – | 43.7% | 3,960.0% | 3,076.9% | – | 5.0% | 4.1% | – | 7.9% | 6.0% | 6.4% | 3.6% | 2.9% | 2.4% | 2.1% | 1.8% | 3.9% | 4.8% | 13.6% | 14.3% | 19.4% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | 0.0% | – | – | – | – | – | |
| -737.4% | -480.6% | -11,046.7% | -61,411.5% | -54,355.6% | -114,964.7% | -93,458.8% | – | – | -1,622.5% | -120,740.0% | -126,107.7% | – | -223.7% | -294.9% | – | -209.4% | -129.2% | -222.6% | 23.2% | -8.5% | 41.3% | 84.6% | 21.9% | -39.7% | 33.4% | -364.8% | -216.9% | -137.4% | -2,379.1% | -973.0% | 41.4% | -6,248.8% | – | -1,610.0% | 5,330.9% | -7,942.9% | -10,746.5% | -50,233.3% | – | -10,906.2% | |
| 30.1% | 5.0% | 219.0% | 1,073.1% | 933.3% | 235.3% | 2,058.8% | – | – | 23.0% | 3,270.0% | 3,115.4% | – | -36.2% | 4.1% | – | 8.0% | 4.1% | 6.4% | 3.6% | 64.8% | 0.5% | -53.0% | 13.4% | -1.5% | -1.7% | 17.9% | 19.0% | 23.3% | -229.9% | 2.4% | 0.4% | – | – | – | – | – | -970.7% | – | – | – | |
| -737.4% | -480.6% | -11,046.7% | -61,411.5% | -54,355.6% | -114,964.7% | -93,458.8% | – | – | -1,622.5% | -120,740.0% | -126,107.7% | – | -223.7% | -294.9% | – | -209.4% | -129.2% | -222.6% | 23.2% | -73.3% | 40.9% | 84.6% | 21.9% | -38.1% | 35.1% | -364.8% | -216.9% | -137.4% | -2,149.3% | -973.0% | 41.4% | -6,248.8% | – | -1,610.0% | 5,330.9% | -7,942.9% | -9,775.7% | -50,233.3% | – | -10,422.5% | |
| -690.5% | -460.9% | -10,700.0% | -59,569.2% | -52,622.2% | -111,776.5% | -90,405.9% | – | – | -1,558.1% | -114,970.0% | -121,492.3% | – | -196.1% | -287.3% | – | -198.7% | -121.2% | -211.8% | 29.8% | -3.0% | 44.8% | 88.6% | 25.0% | -33.2% | 41.8% | -347.7% | -199.3% | -115.1% | -2,375.8% | -969.9% | 42.0% | -6,174.9% | – | -1,504.9% | 5,528.5% | -7,808.8% | -10,682.3% | -49,444.9% | – | -10,670.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.